Kyowa Kirin to acquire Orchard Therapeutics for $478 mln

Kyowa Kirin

05/10/2023 09:31

TOKYO, Oct 5 (Reuters) - Japanese pharmaceutical firm
Kyowa Kirin  4151.T  said on Thursday it would acquire
Britain-based biopharmaceutical company Orchard Therapeutics for
$477.6 million, aiming to promote the development of new drugs. 
    Kyowa said the acquisition has already been cleared by the
two firms' boards of directors but requires approval by the
British company's shareholders. It expects the deal to be
completed in the first quarter of 2024.

 (Reporting by Kiyoshi Takenaka; Editing by Edmund Klamann)
 ((kiyoshi.takenaka@thomsonreuters.com; +81 3 4563 2788;))